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Abstract: Samples of total blood (1T-6T) were collected from six patients (1-6) with Systemic Sclerosis (SSc) and ana-
lyzed for their content of mercury, lead, antimony, cobalt, copper, and zinc through AASGF (atomic absorption spectros-
copy – graphite furnace), HR-ICP-MS (high resolution inductively-coupled plasma mass spectroscopy) and CVAAT (cold 
vapor atomic absorption technique). The blood samples (7CT, 8CT) from two “healthy subjects” (7, 8) were also col-
lected and analyzed. Furthermore, plasma samples (1P-6P, and 7CP and 8CP) were prepared from fresh blood samples 
and analyzed for the same elements. The summary for Hg, usually considered highly toxic, is as follows. Interestingly, 
three of six total blood samples had concentrations of mercury (1T, 11.0(4) μg/L; 2T, 8.2(3); 4T, 7.4(3)) significantly 
higher than the control from this work (5.6(6) μg/L) and the control from the literature (5.3 μg/L). The concentration of 
lead for the total blood samples is in the range 82.7(5) – 36.9(5) μg/L and agrees well with average values for women 
from literature, 70 μg/L. The average concentration for the essential element zinc for the samples 1T-6T is 6658 μg/L, 
which compares well with the mean value from literature (5561 μg/L for “healthy subjects”). 
INTRODUCTION 
 Significant toxic compound and heavy element intake by 
the body is considered a potential co-factor in triggering 
auto-immune diseases [1-3]. To our knowledge, there have 
been no large systematic investigations on the concentration 
of heavy elements in the body of patients with auto-immune 
diseases. Among other auto-immune diseases, systemic scle-
rosis or scleroderma (SSc) is a multi-system disorder charac-
terized by Raynaud’s phenomenon, proliferative vascular 
lesions and abundant deposition of collagen in the skin and 
internal organs (notably the heart, lungs, kidneys, and gastro-
intestinal tract) [4]; the etiology and pathogenesis of SSc are 
unknown. Although the characteristics of the disease are 
multi-factorial, immune system activation plays a central 
role in the development of its pathology; in fact, several cy-
tokines, including IL-2, IL-6, TNF-?, are known to be cru-
cial in the development of tissue remodeling in SSc. Fur-
thermore, mononuclear cells and T-cells predominate in the  
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dermal infiltrate in the inflammatory stages of SSc, and they 
show excessive functional activity in the peripheral blood of 
SSc patients [5-7]. 
 Mercury, cadmium, lead, arsenic, antimony and tin are 
non-essential, toxic elements. They tend to accumulate in 
food chains and they have long biological half-lives in hu-
mans. However, it has yet to be mentioned that trace ele-
ments that are considered toxic can become of nutritional 
significance under certain circumstances of physiologic 
stress in animals and humans [8]. Furthermore, beneficial 
effects on human health of arsenic compounds have been 
reported; for example, in the case of treatments of certain 
diseases like leukemia [9]. Some authors have previously 
claimed that arsenic might have nutritional value in certain 
conditions [10]. Cobalt, copper, and other heavy metals are 
essential trace elements, but they too are toxic when their 
concentrations are relatively high. Possible mechanisms of 
action of these metals might include inhibition of enzymes, 
denaturation of protein, or increased susceptibility to infec-
tion due to immuno-suppression [11-14]. Metal exposure 
may occur also by contamination of food and drinking water. 
Several authors have suggested that the ingestion of one or 
more heavy elements may be important in the etiology of 
some rheumatic diseases like rheumatoid arthritis and SSc. 
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The work by Casciola-Rosen et al. [15] suggested a model 
for the pathogenesis of SSc in which metals and free oxygen 
radicals play a central and synergic role. This conclusion 
came from experimental studies that showed that the auto-
antigens targeted in diffuse SSc are unified by their suscepti-
bility to fragmentation in metal-dependent reactions that 
require the formation of reactive oxygen species. These stud-
ies show the importance of metal ions and of reactive oxygen 
radicals in damage processes during ischemia-reperfusion, 
and they present evidence for increased generation of these 
radicals in SSc patients. 
 Other studies have subsequently reported that the occa-
sional intake of metals by the body, as well as prolonged 
intake from polluted environments, increases the rate of SSc 
in both males and females. For instance, Arnett et al. [16] 
showed that the mean urinary mercury levels were signifi-
cantly elevated in anti-fibrillarin antibody-positive patients 
with SSc when compared to those in other patients without 
anti-fibrillarin antibodies and controls. These findings sug-
gested that further epidemiological and basic science studies 
about the effects of mercury are necessary in patients with 
SSc, especially those expressing anti-fibrillarin antibodies. 
Overzet et al. [17] wished to determine whether SSc auto-
antigens, such as small nucleolar RNP SC-auto-antigens, 
associate with phosphorylated serine/arginine splicing fac-
tors during apoptosis (a similar effect had been shown for 
patients with systemic lupus erythematosus); thus, they 
screened a panel of monoclonal antibodies derived from 
mice exposed to mercury. They concluded that the immune 
response to fibrillarin that characterizes a subset of patients 
with SSc may be related to cell death induced by apoptotic 
stimuli (e.g., irradiation or chemical toxin, etc.) or by expo-
sure to mercury. 
 Kuchma et al. [18], in a study aimed to determine the 
effect of a high level of industrial pollution on the develop-
ment of Raynaud’s syndrome and pulmonary arterial hyper-
tension in patients with SSc and lupus erythematosus, 
showed that people living in highly polluted areas had a se-
vere course of Raynaud’s syndrome. Metal accumulation 
was decisive in patients with SSc in the development of 
Raynaud’s syndrome, and the key role was assigned to lead 
and other heavy metals. The conclusions by the authors are 
that vascular disorders in patients with SSc living in heavily 
contaminated areas are aggravated due to direct damage 
from heavy metals. There are also other studies reporting 
data relevant to the effects played by metals on the immune 
system [19-23]. Very recently, many studies have been fo-
cused on the relationships between heavy metal exposures 
and autoimmune diseases (see for examples Refs 24-27). 
Research on the content of trace elements in non-articular 
rheumatism syndromes has been carried out in the recent 
years (see for an example Ref 28). 
 In connection with these premises, some of us have re-
cently performed a series of analytical determinations of the 
levels of vanadium, cobalt, arsenic, lead, mercury, chromium 
and other elements in the drinking water of the Siena coun-
tryside, especially that from the Amiata mountain area, 
which is volcanically active and rich in metal- and As-
sulfide-containing mineral deposits [29]. A preliminary epi-
demiological and statistical study was also performed on 
certain autoimmune diseases, AIDs (SSc, lupus erythemato-
sus and rheumatoid arthritis), and cancer diseases with pa-
tients from the entire district of Siena [30]. The data showed 
a peak for the year 1995 (4.8 patients with AID per 100,000 
residents) and a smooth decrease in the rate of AIDs up to 
the year 2000 (2.3 patients with AIDs per 100,000 residents). 
A preliminary statistical study directed by one of the authors 
(RM) and conducted during the past ten years at the clinic of 
Rheumatology, University of Siena, on the rate of SC in pa-
tients from the volcanic Amiata mountain area population, 
showed significantly higher values when compared to a con-
trol population.
1
 
 It should be noted that the reference values for most of 
the trace elements in blood, urine, tissues and organs in hu-
mans and other animals is currently a matter of intensive 
research in several laboratories world-wide [31-32]. 
 On the basis of these facts, we planned to determine the 
content of a series of heavy elements in the blood and 
plasma of patients affected by SSc. The patients were chosen 
from those treated at the Clinic of Rheumatology at the Uni-
versity of Siena. They included women aged 42-69; differ-
ences in their area of residence, nutrition and life habits were 
not significant. 
 As SSc is a rare auto-immune disease the number of pa-
tients that could be selected was small [4]. 
EXPERIMENTAL SECTION 
 Sample Collections: Informed consent was obtained for 
all patients and controls before the study. Fifteen milliliters 
of blood was drawn from the SSc patients at the clinic of 
Rheumatology, University of Siena. There were six patients 
(all females, mean age 54±14 y) who fulfilled the prelimi-
nary criteria for SSc of the American College of Rheumatol-
ogy [33] and two sex- and age-matched controls (females, 
mean age 49±4 y). 
 The disease duration was 6.0±2.6 y. All patients had skin 
involvement (limited in two patients and diffuse in the re-
maining), while the internal organs were affected in all pa-
tients. All patients were under treatment with Iloprost (0.15 
mg/month). 
 All of the patients were from Italy; three lived in Siena, 
one in Florence, one in Perugia, and one on the island of 
Capri (Naples). 
 The working activities of the patients are as follows: two 
were housewives; one, a nurse; one, an office-worker; one, a 
trader; and one, a farmer. 
 Preparation of the Samples: Each 15 mL sample of 
total blood was divided into two parts: one (7.5 mL) was the 
total blood sample (xT) which was stored at 4°C, and the 
other (7.5 mL) was centrifuged at 800g to separate the 
plasma fraction (xP) from the heavy red-cell fraction; this 
was collected and stored at 4 °C. All of the total blood sam-
ples and plasma samples were mineralized (see below). 
 Mineralization Procedure: Nitric acid (6 mL Suprapur
®
 
HNO3 65%, w/w; Merck, Darmstäd, Germany) and hydrogen 
peroxide (1 mL, Suprapur
®
 H2O2 33%, w/w, Merck) were 
added to each sample (2.00 g). All of the samples and the 
blank (6 mL, HNO3 65%; 1 mL, H2O2 33%) were put in 
                                                
1 Marcolongo, R. unpublished data, 2007. 
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poly-tetra-fluoro-ethylene (Teflon
®
, PTFE) vessels, which in 
turn, were loaded into a microwave oven (Etos 900, Micro-
wave Labstation; Milestone, MLS-1200 Mega) and heated 
under rotation (Rotore MRD-1000) for 25 minutes. The 
time/power program applied during the mineralization proc-
ess is listed in Table 1. Then, the PTFE vessels were cooled 
down to 25 °C, the mixtures were centrifuged at 4000 rpm 
and the supernatants were diluted to 100 mL with ultra-pure 
H2O. The mineralized samples and the blank were analyzed 
via AAS, HR-ICP-MS, and CVAAT (see below). 
Table 1. Time/Power Program for the Mineralization Proce-
dure 
 
Step Time (min) Power (Watt) 
1 2 250 
2 2 0 
3 6 250 
4 5 400 
5 5 650 
6 0 0 
 
 Atomic Absorption Spectroscopy (AAS): These analy-
ses were performed by using a Perkin Elmer Aanalyst100 
machine equipped with an HGA-800 spectrometer and an 
AS-72 auto-sampler (Perkin-Elmer) with atomization atmos-
phere and a cooling stream of ultrapure argon. The graphite 
tubes used for the analyses were usually a pyrolitic-type 
without platform (Perkin-Elmer), except in a few cases when 
measurements were carried out with L’vov concave platform 
graphite furnace tubes (Perkin-Elmer). All lamps used were 
hollow cathode multi-element lamps, except for Pb. The 
sample volume was 20 mL for all the samples. The thermal 
programs for all the elements are reported in Table 2 and 
consist of drying, pyrolysis and atomization steps. Standard 
solutions (1 g/L of metal, each from Merck) of M(NO3)2, 
(M; Co, Pb), ultrapure Cu, in 0.5 mol/L nitric acid were 
freshly diluted before the analyses. The data collection was 
performed via a WinLab Ver.3.2 package run on a Pentium 
machine. 
Table 2. AAS Thermal Program. The Values Represent, in 
Order, Temperature (°C), Ramp Time (s), and Pla-
teau Time (s) 
 
 Drying Pyrolysis Cooling Atomization Cleaning 
Co 
120 
20/20 
500 
10/15 
20 
5/10 
2500 
0/5 
2600 
1/3 
Cu 
120 
20/20 
500 
10/20 
20 
5/10 
2300 
0/5 
2600 
1/3 
Pb 
120 
10/15 
700 
10/15 
20 
10/10 
1800 
0/5 
2600 
5/3 
 
 
 High Resolution Inductively-Coupled Plasma-Mass 
Spectrometry (HR-ICP-MS): The analyses were performed 
on the samples by using a Perkin Elmer ELAN 6100 instru-
ment and Elan Instrument Software Ver.3.3. Selected ana-
lytical conditions and parameters are reported in Table 3. 
 Three certified standard materials were used for com-
parative purposes: GBW-07603, vegetable materials (Na-
tional Research Centre for Certified Reference Materials, 
Beijing, China); SRM-966, bovine blood (National Institute 
of Standards and Technology, NIST, Gaithersburg, MD; 
USA), and Seronorm
TM
 Trace Element Human Serum Level 
1 (REF 20140, LOT MI0181, SERO AS, P.O. Box 24 No-
1375 Billingstad, Norway). They were freshly prepared. 
Table 3. ELAN 6100 Instrumental Conditions and Method 
Parameters for HR-ICP-MS 
 
Condition/Parameter Value/Method 
RF power (Watt) 1050 
Plasma argon flow (L/min) 15  
Nebulizer gas flow (L/min) 0.9-1.0  
Sample uptake rate (mL/min) 1.5  
Sample introduction system Cross-flow with spray chamber 
Detector mode Dual mode 
Lens Autolens 
Sample/skimmer cones Nickel 
Scanning mode Peak hopping 
Number of sweeps/readings 10 
Number of replicates 4 
 
 Analysis of Total Mercury through the Cold Vapor 
Atomic Absorption Technique, (CVAAT): The analyses 
were performed by using the CETAC M6000A in continuous 
flow, double ray, equipped with 2 quartz cells, a tin(II) chlo-
ride reactor, gas-liquid separation system, NAFION
®
 drying 
device, and mercury vapor lamp. The mineralized samples (5 
mL each) were previously mixed with KMnO4 (50 μL, 5%). 
The selected instrumental details are reported in Table 4. 
Table 4. Instrumental Conditions for CVAAT 
 
Condition/Parameter Value/Method 
Cell length (mm) 220 
Cell temperature (°C) 70 
Gas flow (N2, mL min
-1) 100 
Number of replicate measurements  4 
Base line beginning acquisition time (s) 12 
Base line ending acquisition time (s) 16 
Wavelength (nm) 253.7 
Aqueous reducing solution (w/w) SnCl2·2H2O, 10%, HCl, 7%  
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RESULTS AND DISCUSSION 
 The concentration of the elements analyzed for all the 
samples are reported in Table 5 (the patients are marked 1-
6). The concentration for element X in the blood and plasma 
are C
T
X and C
P
X, respectively. The selected values consid-
ered as references for blood and plasma for “healthy sub-
jects” found in the literature are reported as RV
T
X and RV
P
X. 
Control samples from this laboratory were obtained from the 
blood of two “healthy women”, who had never been diag-
nosed with SSc or any other auto-immune disease. The pa-
tients and controls were in the age range of 42-63 year. 
 Mercury: The C
T
Hg values for the 1T, 2T and 4T sam-
ples (11.0(4), 8.2(3), 7.4(3) ? μg/L, average 8.9(19)) are higher 
than the value obtained by Minoia et al. (5.3 μg/L) [34] and 
much higher than the value obtained by Schober et al. (aver-
age 1.19 μg/L) [35]. The latter, more recent, study was per-
formed through the CVAAT technique on total blood sam-
ples from 759 women aged 30-49 y. The reference value 
determined for adults with a fish consumption of 2-3 meals 
per month is 2.0 μg/L from 2310 samples collected from the 
general population [36]. It is noteworthy that the values ob-
tained in the present work for the NIST standard blood, 
which were declared to be 31.4±1.7 μg/L, are 28.7(6) μg/L. 
Therefore, the values determined in this laboratory for SSc 
patients and for healthy subjects are reliable. The C
T
Hg values 
for 3T, 5T and 6T (3.8(2), 1.64(7) and 1.58(7) μg/L) as well 
as those for the two controls (7T and 8T, 2.5(1) μg/L) com-
pare well with those from the extensive work by Schober 
[35]. It should be noted that the C
T
Hg is higher than C
P
Hg 
(3.5(2), 4.2(2), 1.85(8), 3.9(1), 1.61(7), 1.27(7) μg/L, 1P-6P) 
for all samples (average 2.7(13)). The corresponding values 
for the controls are 0.88(5) and 0.15(4) μg/L (7P and 8P). It 
should be noted that the concentrations of mercury from the 
Seronorm
TM
 standard as declared and as found from this 
work are 0.96±0.10 and 0.85±0.07 μg/L, respectively. 
 On the basis of these data, it seems that the majority of 
patients with SSc (four out of six) have a content of Hg in 
their blood that is higher than that of both the two relevant 
study controls and the average values taken from previous 
studies by others. This fact does not prove a correlation be-
tween the content of Hg in blood and SSc disease; however, 
it at least suggests that a wider analytical and epidemiologi-
cal investigation should be performed, by selecting a larger 
number of patients from both sexes. In regards to patients 1, 
Table 5. Concentration of Selected Elements (μg/L) in the Blood Samples (xT) and the Blood Plasma (xP) from Patients with SSc 
(1-6), Obtained via HR-ICP-MS. Reference Values (RV) for Blood Samples from Healthy Subjects are Reported in the 
Text for Comparative Purposes. Controls from this Work are 7 and 8 (See Text) 
 
 Hg
a 
Pb Sb Co Cu Zn 
1T 11.0(4) 72.6(5) 1.06(3) 0.58(3) 896(3) 3760(20) 
1P 3.5(2) 42.9(4) nd nd 1128(4) 1457(12) 
  <75b  <25b 1001(10)b  
2T 8.2(3) 45.1(5) 2.38(4) 1.04(4) 846(3) 6351(23) 
2P 4.2(2) 40.6(4) 1.77(3) 0.92(3) 1051(4) 1951(12) 
  <75b  <25b 1060(8)b  
3T 3.8(2) 73.6(5) 1.95(3) 2.70(5) 1057(4) 4074(20) 
3P 1.85(8) 67.9(5) 1.77(4) 1.01(3) 1243(5) 1818(12) 
  <75b  <25b 1252(8)b  
4T 7.4(3) 42.2(5) 0.94(2) <0.05 826(3) 10394(30) 
4P 3.9(1) 28.8(5) 0.65(2) <0.05 998(3) 2723(18) 
5T 1.64(7) 36.9(5) 0.52(2) <0.05 794(3) 6652(22) 
5P 1.61(7) 4.8(3) nd <0.05 872(4) 1751(18) 
6T 1.58(7) 82.7(5) 1.80(3) 0.20(2) 961(4) 8714(25) 
6P 1.27(7) 4.5(3) 0.80(2) nd 926(4) 2926(20) 
7T 2.5(1) 26.6(4) 0.79(2) <0.05 1043(4) 7577(25) 
7P 0.88(5) 7.6(3) 0.48(1) <0.05 1056(4) 1777(12) 
8T 2.5(1) 96.1(6) 0.51(2) <0.05 887(3) 8037(25) 
8P 0.15(4) 82.6(6) 0.65(3) <0.05 1099(4) 3456(20) 
a The values for Hg were obtained through CVAAT. 
b Values from AAS. As regrds Pb and Co the detection limits for AAS were 75 and 25 μg/L, respectively, because fifty times dilutions after mineralization. 
nd, not determined. 
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2 and 4 (C
T
Hg values higher than the mean values 5.5(5) μg/L 
out of six), it should be noted that all of them had more than 
ten dental amalgams for many years. Patient 1 was a ciga-
rette smoker (ca 7/d) for two decades. A specific high inges-
tion of mercury from polluted water and meals had appar-
ently not played a role for this patient, based on her nutri-
tional habits. She lives in an area that is not significantly 
polluted by emissions from industrial settlements, car traffic, 
agriculture activities, etc. She worked as a nurse for two dec-
ades in a main regional clinic. 
 One of the referees suggested that the contents of trace 
elements in the blood might vary with age. In fact, it should 
be noted that patients 1 and 4 are 65 and 69 years old, re-
spectively, whereas the mean age of patients 3, 5 and 6 is 
51.4±2.5 y. These data confirm the hypothesis of the re-
viewer, even though patient 2 (42 years old) does not fit this 
pattern. The patients’ diets in the period of time before the 
sample collections are not known. 
 Lead: The concentration of lead for the blood samples, 
C
T
Pb (72.6(5), 45.1(5), 73.6(5), 42.2(5), 36.9(5), 82.7(5) 
μg/L, 1T-6T, average 58.9(16)), agrees well with recent 
mean values for women (70 μg/L) obtained from Wilhelm 
M. et al. [36]. The lead concentration in blood samples from 
a Detroit (Michigan) female population (885 adults) was 
found to be as low as 27 μg/L (average) by Nriagu et al. 
[37]. The C
T
Pb values for the two controls are 26.6(4) and 
96.1(6) μg/L (7T and 8T, respectively). It should be noted 
that the C
T
Pb values are higher than the corresponding C
P
Pb 
values (42.9(4), 40.6(4), 67.9(5), 28.8(5), 4.8(3), 4.5(3) μg/L, 
1P-6P, average 31.6(244) μg/L). The two controls have CPPb 
values of 7.6(3) and 82.6(6) μg/L. In conclusion, the concen-
tration of lead is not significantly higher than the reference 
values in six out of eight of the samples analyzed in this 
study. SSc pathologies seem not to be correlated with an 
anomalous concentration of Pb in blood and plasma. The 
value determined in this work for the NIST blood sample 
differs by less than 8% from that declared (253±2.2 μg/L). 
The concentration for lead in the Seronorm
TM
 human serum 
standard is 2.20(5) μg/L, in good agreement with the de-
clared one (2.9(1) μg/L). 
 Antimony: The concentration of antimony for the total 
blood samples, C
T
Sb (1.06(3), 2.38(4), 1.95(3), 0.94(2), 
0.52(2), 1.80(3) μg/L, 1T-6T, average 1.44(71)), is close or 
lower than the mean value found in previous work by others: 
3.19 μg/L [38]. The CPSb values (1.77(3), 1.77(3), 0.65(2) 
μg/L, 2P-4P, 0.80(2) μg/L for 6T, 1.30(54) average) are 
close to the values found for total blood samples. The values 
for the two controls are 0.79(2) and 0.51(2) (T), and 0.48(1) 
and 0.65(3) μg/L (P), respectively. The value found for the 
NIST bovine blood standard is 3.28(4) μg/L, whereas for the 
Seronorm
TM
 human serum standard, the concentration of Sb 
is 10.6(6.3) μg/L (declared) and 9.4(2) (found). These data 
show that antimony is not present in higher concentrations in 
the blood of the six SSc patients when compared to 
“healthy” people. A recent analytical study suggested that 
antimony might be a sensitive indicator (together with lead 
and manganese) of diseases connected with blood pressure 
and/or the renal system (preeclampsia among women with-
out occupational exposure) (Vigeh et al., 2006, and refer-
ences cited therein). 
 Cobalt: The cobalt concentrations in blood samples for 
three patients out of six (0.58(3), 1.04(4), 2.70(5) 1T-3T) are 
a little higher than the average value (0.39 μg/L) found by 
Minoia et al. [34], and are also in agreement with the mean 
value found by Vigeh et al. (0.54 μg/L) [38]. The other three 
patients had very small C
T
Co values (<0.05 μg/L, 4T and 5T 
and 0.20(2), 6T). The C
P
Co values for plasma (0.92(3), 
1.01(3), <0.05, <0.05 μg/L, 2P-5P) are not much different 
from the corresponding C
T
Covalues. The concentration of 
cobalt found in the two controls from this work is lower than 
0.05 μg/L for both blood and plasma. The concentration of 
cobalt found in the vegetal standard is 0.41(2) μg/L (declared 
0.41±0.03), whereas the values found for the Seronorm
TM
 
human serum standard are 1.12(2) μg/L (declared) and 
0.96(4) μg/L, respectively. 
 Copper: The C
T
Cu values for blood (896(3), 846(3), 
1057(4), 826(3), 794(3), 961(4) μg/L, 1T-6T, average 
897(98)) are a little lower than the values reported by Minoia 
et al. (1200 μg/L) [34] and the values reported by others: 
1068-1461 μg/L [39] and 1075 μg/L for eight healthy Mexi-
can women [40]. The C
P
Cu are values are 1128(4), 1051(4), 
1243(4), 998(3), 872(4), 926(4) μg/L for patients 1P-6P, 
with an average of 1036(135) μg/L. It should be noted that 
the C
T
Cu values are lower than the corresponding C
P
Cu values 
in five out of six patients. The values for the two controls 
from this work are 1043(4) and 887(3) μg/L (average 
965(110)) for blood and 1056(4) and 1099(4) μg/L (average 
1078(30)) for plasma. The value for the NIST total blood 
bovine standard is 1203(4) μg/L. The values for the Sero-
norm
TM
 human serum standard are 1180±90 μg/L (declared) 
and 1153(4) μg/L (found). It appears that the content of cop-
per in blood from SSc patients is not a specific anomaly 
when compared to the standard controls from this work. It 
therefore seems that the SSc patients have a lower content of 
copper than healthy patients; interestingly, this could be re-
lated to the role played by copper in inflammation and in 
oxygen radical concentrations. 
 Zinc: The concentration of zinc in the total blood sam-
ples (C
T
Zn) averages 6658(2583) μg/L (3760(20), 6351(23), 
4074(20), 10394(30), 6652(22), 8714(25) μg/L, 1T-6T) as 
compared to RV
T
Zn (6340 μg/L) [34] and to the mean value 
from other authors (5561(1057) μg/L [38]). The values for 
the two controls from this work are 7577(25) and 8037(25) 
μg/L. The average CPZn value of 2104(584) μg/L (1457(12), 
1951(12), 1818(12), 2723(18), 1751(18), 2926(20) μg/L, 1P-
6P) is higher than the RV
P
Zn (922 μg/L) [34]. The values for 
the controls from this work are 1777(12) and 3456(20) μg/L. 
The values found for the Seronorm
TM
 human serum standard 
are 1330±100 (declared) and 1354(6) μg/L, respectively. The 
average value for C
T
Zn agrees with the value from previous 
work, but the individual values span a large interval. Patient 
1 has a small C
T
Zn value and patient 4 has a high C
T
Zn value 
when compared to the mean values from this work and those 
from other works. It seems that the metabolism of this essen-
tial element might be significantly altered for subjects with 
SSc. 
CONCLUSIONS 
 This work shows a substantial agreement for the concen-
trations of the selected elements when analyzed through the 
three different techniques. The reliability of the methods was 
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assured by the results obtained for blood standards from the 
NIST and a GBW vegetal standard. Notwithstanding, HR-
ICP-MS technique with the procedure used in this work 
overestimated the content of mercury in blood and, at a 
lesser extent in plasma, whereas CVAAT was much more 
reliable. For this reason the values for mercury reported in 
the present work are those obtained via CVAAT. It has to be 
noted that a methodology for determination of mercury, 
cadmium and lead in blood using HR-ICP-MS has been de-
veloped, validated and is now in press [41]. 
 Even though the small number of SSc patients examined 
(it has to be noted that SSc affects 200-300 persons per mil-
lion, and overall population of Siena is below 60,000) does 
not allow any concrete correlation between the concentration 
of an element and the diagnosis of SSc disease, it can be 
noted that: (1) high concentrations of mercury were found in 
three out of six patients; (2) high concentrations of cadmium 
were found in two SSc patients; (3) the concentrations of 
copper are smaller in SSc patients than in “healthy subjects” 
from other works and a little smaller than those from the two 
controls used here; and (4) the concentrations of zinc in these 
SSc patients range from 3760-10394 μg/L, showing a larger 
variability than for copper and zinc found in non-SSc people. 
Therefore, it is highly advisable that a more thorough ana-
lytical work be performed by increasing the number of SSc 
patients, the number of samples collected from each patient 
as function of time from diagnosis, and the number of sam-
ples from the “healthy subjects,” with the aim of defining a 
reliable reference value for each element. Other elements 
should also be included in the panel, and specific sampling 
strategies should be designed and performed. For example, 
patients might be selected from restricted areas or based on 
genetic characteristics, nutritional styles, sex, other diseases 
diagnosed before SSc, etc. Work is planned in this clinic and 
these chemical laboratories with the purpose of increasing 
the number of samples and patients whose disease was diag-
nosed shortly before sample collection, and to study the in-
fluence of anti-SSc therapy on the metabolism of heavy ele-
ments. Finally, analysis of the trend for the Hg content in the 
blood of patients with SSc as it relates to age confirms that 
this heavy metal accumulates even under scleroderma condi-
tions. On the contrary, no such relationship could be con-
firmed for the other trace elements. 
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